|
Symbol
|
WEVLTQ | LTARCH | WXNLTQ | XRYLTQ | RMABXV | YOTLTQ | RMBWDV | RMAVSV | Z0972Z | Z0974Z | Z0973Z | ZPRLTQ | OCGRCH | HZJEFG | BZFBKB | ABOOSQ | SKS4LK | LTHCLK | OOJRCH | CAHBKB |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Multi Reverse Convertible | Worst of Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Multi Vonti | Multi Vonti | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Reverse Convertible | Reverse Convertible | Multi Reverse Convertible | LUKB Softcallable Multi Reverse Convertible | LUKB Softcallable Multi Reverse Convertible | Worst of Callable Reverse Convertible | Reverse Convertible |
|
Sous-jacent
|
Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG / Zurich Insurance Group AG | Geberit AG / Givaudan / Holcim/Amrize Basket / Roche AG / Zurich Insurance Group AG | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Compagnie Financière Richemont SA / Novartis Sandoz Basket / Roche AG / Swatch Group I / Swiss RE AG | Nestlé / Novartis / Roche GS | Nestlé / Novartis / Roche GS | Nestlé / Novartis / Roche GS / UBS / Zurich | Holcim/Amrize Basket / Kühne & Nagel Intl. AG / Nestlé S.A. / Novartis AG / Roche AG | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Nestlé / Novartis / Roche GS / UBS / Zurich | Lonza Group N / Roche GS / Sika AG | ABB N / Kühne & Nagel Intl. AG / Roche GS / Swisscom N / Zurich Insurance Group AG | ABB N / Kühne & Nagel Intl. AG / Roche GS / Swisscom N / Zurich Insurance Group AG | Julius Baer Group / Roche AG / Straumann Hldg. AG | ABB N / Nestlé N / Novartis N / Roche GS / Swiss RE AG | Barry Callebaut AG / Nestlé S.A. / Roche AG / Swiss RE AG / UBS Group AG | ABB N / Kühne & Nagel Intl. AG / Roche GS / Swisscom N / Zurich Insurance Group AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
31.03.2028 | 24.09.2027 | 30.06.2028 | 22.09.2028 | 12.10.2026 | 24.11.2027 | 27.07.2026 | 23.02.2026 | 04.03.2026 | 04.03.2026 | 04.03.2026 | 23.04.2027 | 26.04.2027 | 02.11.2026 | 12.07.2027 | 05.07.2027 | 10.07.2026 | 09.07.2027 | 15.07.2026 | 19.07.2027 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
71,27 | 55,98 | 70,71 | 160,62 | 77,13 | 74,2425 | 63,33 | 197,50 | 22,9033 | 22,9279 | 22,9033 | 45,96 | 58,5776 | 182,298 | 183,056 | 177,072 | 39,21 | 58,7776 | 60,164 | 176,528 |
| rendement max. p.a. | 5,25% | - | 6,60% | 7,89% | 9,82% | 6,07% | 4,64% | - | -10,67% | -7,89% | -9,10% | 3,14% | 4,39% | - | 13,03% | 12,35% | 10,81% | 5,67% | 6,80% | 11,57% |
| Demande | 101,36 | 107,63 | 94,71 | 91,36 | 96,40 | 97,22 | 99,50 | - | - | - | - | 103,82 | 99,06 | 83,68 | 91,59 | 92,07 | - | - | 99,07 | 92,72 |
| Offre | 102,17 | - | 95,51 | 92,16 | 97,40 | 98,02 | 100,50 | - | - | - | - | 104,65 | 99,86 | - | 92,39 | 92,87 | - | - | 99,87 | 93,52 |